SSHD informed DHSS that the Biomedical Research Committee had decided not to support the ALT and anti-HBc screening of blood donation multi-centre study and the applicants were not allowed to resubmit. Read more about SSHD informed DHSS that the Biomedical Research Committee had decided not to support the ALT and anti-HBc screening of blood donation multi-centre study and the applicants were not allowed to resubmit.
D Macniven commented that decision on whether or not to put resources into NANB testing should be properly informed by research. He suggested that "the worst of all possible worlds is that research cannot get off the ground and that they would be subjected to irresistible pressure to spend the money in any case, for the sake of improving the safety of blood and blood products. Read more about D Macniven commented that decision on whether or not to put resources into NANB testing should be properly informed by research. He suggested that "the worst of all possible worlds is that research cannot get off the ground and that they would be subjected to irresistible pressure to spend the money in any case, for the sake of improving the safety of blood and blood products.
The CSO's Biomedical Research Committee rejected the SNBTS NANBH screening research proposal on scientific grounds. Dr Forrester suggested deferring the decision being announced until the CSO had coordinated its actions with the DHSS, and envisaged that the DHSS might wish to take over the research proposal by adding a fourth English centre to the study. Read more about The CSO's Biomedical Research Committee rejected the SNBTS NANBH screening research proposal on scientific grounds. Dr Forrester suggested deferring the decision being announced until the CSO had coordinated its actions with the DHSS, and envisaged that the DHSS might wish to take over the research proposal by adding a fourth English centre to the study.
Dr Brian McClelland and Dr John Gillon applied to the Biomedical Research Committee of the SHHD's CSO for funding to enable the RTCs to participate in the multi-centre study on NANBH surrogate testing. Read more about Dr Brian McClelland and Dr John Gillon applied to the Biomedical Research Committee of the SHHD's CSO for funding to enable the RTCs to participate in the multi-centre study on NANBH surrogate testing.
Dr Brian McClelland submitted an application to Biomedical Research Committee relating to the study on NANBH infection in blood donors and the possibility of surrogate testing Read more about Dr Brian McClelland submitted an application to Biomedical Research Committee relating to the study on NANBH infection in blood donors and the possibility of surrogate testing
In a letter to Professor Cash, Dr McIntyre stated that SNBTS wished to proceed with the research project into surrogate testing for NANB Hepatitis.. Read more about In a letter to Professor Cash, Dr McIntyre stated that SNBTS wished to proceed with the research project into surrogate testing for NANB Hepatitis..
Minutes of Scottish National Blood Transfusion Service Directors' meeting suggested that previous minutes were incorrect and that the Edinburgh Transfusion Centre would participate in the multi-centre study for surrogate testing for NANB hepatitis. Read more about Minutes of Scottish National Blood Transfusion Service Directors' meeting suggested that previous minutes were incorrect and that the Edinburgh Transfusion Centre would participate in the multi-centre study for surrogate testing for NANB hepatitis.
A memo from Dr J M Forrester to Dr McIntyre in relation to the Scottish Component of Research into Non-A, Non-B Hepatitis and Blood Transfusion Services outlined that there was a suggestion that the Scottish component of the study was being abandoned. It also referenced Dr Brian McClelland's view that "we had better simply institute screening". Read more about A memo from Dr J M Forrester to Dr McIntyre in relation to the Scottish Component of Research into Non-A, Non-B Hepatitis and Blood Transfusion Services outlined that there was a suggestion that the Scottish component of the study was being abandoned. It also referenced Dr Brian McClelland's view that "we had better simply institute screening".
Professor Barbara accepted, when he gave evidence, that it was a premise of his and Professor Contreras's argument that NANBH infections were occasional and that they had the feeling that non-A, non-B was not as severe as hepatitis B. He further described his view of the value of surrogate testing being based on the limited number of post-transfusion hepatitis reports from clinicians. Read more about Professor Barbara accepted, when he gave evidence, that it was a premise of his and Professor Contreras's argument that NANBH infections were occasional and that they had the feeling that non-A, non-B was not as severe as hepatitis B. He further described his view of the value of surrogate testing being based on the limited number of post-transfusion hepatitis reports from clinicians.
The Lancet published a letter in response from Dr Contreras and Dr Barbara, arguing that "Transfusion services must not bow to irrational pressure for measures whose efficacy is unproven". Read more about The Lancet published a letter in response from Dr Contreras and Dr Barbara, arguing that "Transfusion services must not bow to irrational pressure for measures whose efficacy is unproven".